FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity Healthcare FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity technicalzoo January 15, 2025 UAE, January 15 2025: The U.S. Food and Drug Administration (FDA) approved lately Tirzepatide, produced by Eli Lilly, as... Read More Read more about FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
